Abstract
Microvascular and metabolic physiology are tightly linked. This Perspective reviews evidence that 1) the relationship between hyperglycemia and microvascular dysfunction (MVD) is bidirectional and constitutes a vicious cycle; 2) MVD in diabetes affects many, if not all, organs, which may play a role in diabetes-associated comorbidities such as depression and cognitive impairment; and 3) MVD precedes, and contributes to, hyperglycemia in type 2 diabetes (T2D) through impairment of insulin-mediated glucose disposal and, possibly, insulin secretion. Obesity and adverse early-life exposures are important drivers of MVD. MVD can be improved through weight loss (in obesity) and through exercise. Pharmacological interventions to improve MVD are an active area of investigation.
© 2018 by the American Diabetes Association.
MeSH terms
-
Adipose Tissue / blood supply
-
Adipose Tissue / metabolism
-
Animals
-
Combined Modality Therapy
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / metabolism
-
Diabetes Mellitus, Type 2 / therapy
-
Diabetic Angiopathies / complications
-
Diabetic Angiopathies / physiopathology*
-
Diabetic Angiopathies / prevention & control
-
Diabetic Nephropathies / complications
-
Diabetic Nephropathies / etiology
-
Diabetic Nephropathies / prevention & control
-
Diabetic Retinopathy / complications
-
Diabetic Retinopathy / etiology
-
Diabetic Retinopathy / prevention & control
-
Healthy Lifestyle
-
Humans
-
Hyperglycemia / complications
-
Hyperglycemia / physiopathology*
-
Hyperglycemia / prevention & control
-
Insulin Resistance
-
Microvessels / physiopathology*
-
Obesity / complications
-
Obesity / metabolism
-
Obesity / physiopathology
-
Obesity / therapy
-
Prediabetic State / blood
-
Prediabetic State / complications*
-
Prediabetic State / metabolism
-
Prediabetic State / therapy